Santen Pharmaceutical has revised the prices of certain products, with increases ranging from 5.7% to 33.3%. The specific products affected are not identified in the article.
Santen Pharmaceutical has indicated a policy of revising the prices of certain products. The increases are expected to range from 5.7% to 33.3%, but the products affected are not identified in the article.
The article does not provide details such as the names of the products subject to the revisions, the specific revision date or the timing of implementation. It also contains no additional information on the impact on the market or the factors behind the move.